查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1715466

全球神經刺激設備市場按產品類型、材料類型、電源、年齡層、應用和最終用戶分類 - 預測至 2025 年至 2030 年

Neurostimulation Device Market by Product Type, Material Type, Power Source, Age Group, Application, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計神經刺激設備市場規模在 2024 年將達到 72.3 億美元，在 2025 年將達到 80.7 億美元，複合年成長率為 11.89%，到 2030 年將達到 142 億美元。

主要市場統計數據
基準年2024年 72.3億美元
預計2025年 80.7億美元
預測年份 2030 142億美元
複合年成長率（%） 11.89%

神經刺激設備市場已成為醫療技術領域最具創新性的領域之一。最近的進展不僅改善了各種疾病患者的臨床療效，也推動了治療性介入介入的新典範。該領域的特點是發展迅速，突破性的研究和技術改進不斷重新定義護理標準。隨著醫療保健提供者和行業領導者尋求兼具準確性和有效性的解決方案，市場正在對研究、製造和臨床試驗進行大量投資。

精準醫療不再只是一種願望，而是一種現實，相關人員正在尋找能夠提供客製化治療方案的設備。這一日益成長的趨勢是由技術與醫學的無縫整合所推動的，從而帶來了更有效、更可靠、更方便用戶使用的設備。這些發展不僅對於改善患者的生活品質至關重要，而且對於減輕慢性病對醫療保健系統的整體負擔至關重要。隨著監管部門的核准和全球的廣泛採用，神經刺激設備有望成為現代醫學的中流砥柱。

此外，研究人員結合神經學、工程學和材料科學的見解所採用的跨學科方法正在推動設備創新的新時代。這種合作精神體現在實驗室突破迅速轉化為臨床應用，為近期和長期持續的市場成長奠定了堅實的基礎。

正在重新定義治療格局的變革

神經刺激設備市場正在經歷變革時期，重新定義全球治療格局。在研發方面的開創性投資已經產生了利用先進技術以前所未有的精度識別疾病狀況的儀器。隨著研究趨勢的不斷發展，業內公司現在正從傳統的侵入性手術轉向微創和非侵入性替代方案，從而縮短患者的康復時間並提高整體治療滿意度。

數位化整合在這一轉變中發揮著至關重要的作用。先進的感測器和連接功能可以實現即時數據收集，讓臨床醫生可以動態了解患者對治療的反應。這種演變不僅彌合了患者治療結果與設備性能之間的差距，而且強調了個人化治療計劃的重要性。人工智慧和機器學習演算法與神經刺激技術的結合將進一步豐富數據分析，為更具適應性和回應性的干涉鋪平道路。

此外，學術機構和行業創新者之間的新合作正在加速將尖端研究轉化為市場可用的設備。這些合作的重點是利用非常規方法解決設備壽命、病患舒適度和臨床效果等長期存在的挑戰。隨著競爭壓力的增加，公司擴大投資於可擴展的技術，這些技術可以確保效能的一致性，同時確保高安全性和法規遵循。這種模式轉移表明，未來神經刺激設備不僅可以補充傳統治療方法，還可以作為複雜神經系統疾病的獨立解決方案。

透過更深層的市場區隔來調整市場策略

仔細觀察市場區隔可以為神經刺激設備產業背後的多樣化動態提供有價值的見解。依產品類型分類時，會分析多種設備，包括人工電子耳深層腦部刺激器、薦骨神經刺激器、脊髓刺激設備和迷走神經刺激設備。這種細分錶明，每種產品類型都滿足不同的臨床需求，從增強聽力功能到管理複雜的運動障礙。這些設備的開發重點是治療的精準性，以確保從研究到臨床應用的產品生命週期的每個元素都與患者的治療結果一致。

從材料類型來看市場，金屬和聚合物生物材料的使用正在被廣泛考慮。這些材料的選擇通常反映了耐用性和生物相容性之間的權衡，製造商投資於研發以達到最佳平衡，既能提高患者安全性，又不影響性能。類似地，基於電源的主要細分區分為不可充電和可充電神經刺激設備。這種區別至關重要，因為它影響設備的壽命、易用性和整體患者依從性，並且是醫療保健提供者的決策標準。

根據年齡層進一步細分，將市場分為成人、老年人和兒童，每個群體都有自己的生理和臨床特徵，需要不同的方法。此外，基於應用的細分深入研究了胃腸道疾病、聽力損失、神經病變、疼痛管理、睡眠呼吸中止症以及尿失禁和大便失禁的治療。神經系統疾病包括肌張力不全症、癲癇、自發性震顫和帕金森氏症，疼痛管理包括癌症疼痛和慢性疼痛。尿失禁進一步細分為腸道疾病和膀胱過動症。最後，最終用戶細分著重於各種臨床環境，例如門診手術中心、家庭醫療保健、醫院和專科診所。這些見解使相關人員能夠制定適合特定臨床需求和患者人口統計的市場策略。

目錄

第1章 引言

第2章調查方法

第3章執行摘要

第4章 市場概述

第5章 市場洞察

  • 市場動態
    • 驅動程式
      • 神經刺激設備在疼痛管理和慢性病治療的應用日益增多
      • 神經刺激技術的進步改善了患者的治療效果
      • 神經系統疾病盛行率不斷上升，老齡人口不斷增加
    • 限制因素
      • 神經刺激設備和程序的高成本阻礙了新興國家的採用
    • 機會
      • 增加研發投入，擴大神經刺激設備的範圍
      • 各種醫療應用中對微創神經刺激療法的需求不斷成長
    • 任務
      • 神經刺激設備的監管障礙和漫長的核准時間正在減緩市場成長
  • 市場區隔分析
    • 產品類型：薦骨神經刺激器，用於改善膀胱和腸道控制
    • 最終用戶：家庭醫療保健，可長期管理神經系統疾病
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社會
    • 技術的
    • 合法的
    • 環境

第6章神經刺激設備市場（依產品類型）

  • 人工電子耳
  • 深層腦部刺激器（DBS）
  • 薦骨神經刺激器（SNS）
  • 脊髓刺激設備（SCS）
  • 迷走神經刺激設備（VNS）

第7章神經刺激設備市場（依材料類型）

  • 金屬生醫材料
  • 聚合物生醫材料

第8章神經刺激設備市場（按電源）

  • 非充電式神經刺激設備
  • 可充電神經刺激設備

第9章神經刺激設備市場（依年齡層）

  • 對於成年人
  • 老年人
  • 小兒科

第 10 章神經刺激設備市場（按應用）

  • 胃腸道疾病
  • 聽力損失
  • 神經系統疾病
    • 肌張力不全症
    • 癲癇
    • 自發性震顫
    • 帕金森氏症
  • 疼痛管理
    • 癌症痛
    • 慢性疼痛
  • 睡眠呼吸中止症
  • 尿失禁和大便失禁
    • 腸道疾病
    • 膀胱過動症

第 11 章神經刺激設備市場（按最終用戶）

  • 門診手術中心（ASC）
  • 家庭醫療保健
  • 醫院
  • 專科診所

第 12 章：美洲神經刺激設備市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

13. 亞太地區神經刺激設備市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

14. 歐洲、中東和非洲神經刺激設備市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第15章競爭格局

  • 2024年市場佔有率分析
  • 2024年FPNV定位矩陣
  • 競爭情境分析
  • 戰略分析與建議

公司名單

  • Abbott Laboratories
  • Axonics, Inc.
  • Bioness, Inc.
  • Boston Scientific Corporation
  • Cefaly Technology
  • Curonix LLC.
  • InCube Labs.
  • Integra LifeSciences Holdings Corporation
  • LivaNova PLC
  • Medtronic PLC
  • MicroTransponder, Inc.
  • Motif Neurotech, Inc.
  • Nevro Corporation
  • ReShape Lifesciences, Inc
  • Saluda Medical Pty Ltd.
  • SceneRay Co., Ltd
  • Soterix Medical, Inc.
Product Code: MRR-036C5CF3B4E1

The Neurostimulation Device Market was valued at USD 7.23 billion in 2024 and is projected to grow to USD 8.07 billion in 2025, with a CAGR of 11.89%, reaching USD 14.20 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 7.23 billion
Estimated Year [2025] USD 8.07 billion
Forecast Year [2030] USD 14.20 billion
CAGR (%) 11.89%

The neurostimulation device market has emerged as one of the most innovative segments in the medical technology landscape. Recent advancements have not only improved clinical outcomes for patients suffering from a variety of conditions but have also driven new paradigms in therapeutic interventions. This sector is characterized by its rapid evolution, where groundbreaking research and technological refinements are continually redefining the standard of care. As healthcare providers and industry leaders seek solutions that marry precision with efficacy, the market has seen significant investments in research, manufacturing, and clinical experimentation.

In a context where precision medicine is no longer just an aspiration but a reality, stakeholders are demanding devices that offer tailored therapeutic options. This growing trend is anchored in the seamless integration of technology with medical science, leading to devices that are more effective, reliable, and user-friendly. These developments are crucial not just for enhancing patient quality of life but also for reducing the overall burden of chronic conditions on healthcare systems. With regulatory approvals and an expanding global footprint, neurostimulation devices are well poised to become a mainstay in modern medical practice.

Moreover, the multidisciplinary approach adopted by researchers, combining insights from neurology, engineering, and material sciences, is fueling a new era of device innovation. This collaborative spirit is evident in the rapid translation of laboratory breakthroughs into clinical applications, thereby setting a robust foundation for sustained market growth in the near and long term.

Transformative Shifts Redefining the Therapeutic Landscape

The neurostimulation device market is undergoing transformative shifts that are redefining therapeutic landscapes across the globe. Pioneering investments in research and development have yielded devices that leverage advanced technology to target conditions with unprecedented precision. As research trends evolve, industry players are now shifting from traditional invasive procedures towards minimally invasive and non-invasive alternatives, thus reducing patient recovery times and enhancing overall treatment satisfaction.

Digital integration is playing a pivotal role in these shifts. Advanced sensors and connectivity features are enabling real-time data collection, offering clinicians a dynamic view of patient responses to therapies. This evolution is not only bridging the gap between patient outcomes and device performance but is also reinforcing the importance of personalized treatment plans. The blending of artificial intelligence and machine learning algorithms with neurostimulation technology further enriches data analytics, paving the way for more adaptive and responsive interventions.

Additionally, emerging collaborations between academic institutions and industry innovators are accelerating the translation of cutting-edge research into market-ready devices. These partnerships focus on leveraging unconventional methodologies to address longstanding challenges such as device longevity, patient comfort, and clinical efficacy. As competitive pressures mount, companies are increasingly investing in scalable technologies that promise consistency in performance while ensuring high safety and regulatory compliance. Such paradigm shifts hint at a future where neurostimulation devices not only complement traditional therapies but may also serve as standalone solutions for complex neurological conditions.

Deep Dive into Segmentation Insights for Tailored Market Strategies

A closer look at the market segmentation provides valuable insights into the diverse dynamics underpinning the neurostimulation device industry. When categorized by product type, the analysis spans across a spectrum of devices including cochlear implants, deep brain stimulators, sacral nerve stimulators, spinal cord stimulators, and vagus nerve stimulators. This segmentation reveals that each product type addresses distinct clinical needs, from enhancing auditory functions to managing complex movement disorders. These devices have been developed with a specific focus on therapeutic precision, ensuring that each element of the product life cycle-from research to clinical application-remains aligned with patient outcomes.

Examining the market through the lens of material type, the use of both metallic and polymeric biomaterials has been explored extensively. The choice between these materials often reflects a trade-off between durability and biocompatibility, with manufacturers investing in R&D to strike an optimal balance that enhances patient safety without compromising performance. Similarly, a key segmentation based on the power source distinguishes between non-rechargeable and rechargeable neurostimulators. This differentiation is crucial as it influences device longevity, ease of use, and overall patient adherence, serving as a decision-making criterion for healthcare providers.

Further segmentation based on age group divides the market into adult, geriatric, and pediatric demographics, each requiring tailored approaches due to unique physiological and clinical characteristics. Moreover, the application-based segmentation delves into the treatment of gastrointestinal disorders, hearing loss, neurological disorders, pain management, sleep apnea, and urinary and fecal incontinence. A more granular analysis within this category presents neurological disorders in terms of dystonia, epilepsy, essential tremor, and Parkinson's disease, while pain management is examined within the context of cancer pain and chronic pain. Incontinence is further subdivided into bowel disorders and overactive bladder. Lastly, the end-user segmentation highlights varied clinical environments such as ambulatory surgery centers, home healthcare, hospitals, and specialty clinics. These insights collectively empower stakeholders to develop tailored market strategies that align with specific clinical needs and patient demographics.

Based on Product Type, market is studied across Cochlear Implants, Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Spinal Cord Stimulators (SCS), and Vagus Nerve Stimulators (VNS).

Based on Material Type, market is studied across Metallic Biomaterials and Polymeric Biomaterials.

Based on Power Source, market is studied across Non-Rechargeable Neurostimulators and Rechargeable Neurostimulators.

Based on Age Group, market is studied across Adult, Geriatric, and Pediatric.

Based on Application, market is studied across Gastrointestinal Disorders, Hearing Loss, Neurological Disorders, Pain Management, Sleep Apnea, and Urinary & Fecal Incontinence. The Neurological Disorders is further studied across Dystonia, Epilepsy, Essential Tremor, and Parkinson's Disease. The Pain Management is further studied across Cancer Pain and Chronic Pain. The Urinary & Fecal Incontinence is further studied across Bowel Disorders and Overactive Bladder.

Based on End User, market is studied across Ambulatory Surgery Centers (ASCs), Home Healthcare, Hospitals, and Specialty Clinics.

Navigating Regional Dynamics in Global Markets

Regional disparities play a significant role in shaping the neurostimulation device landscape. In the Americas, a surge in technological innovations, supported by robust healthcare infrastructures, is driving significant investments and market expansion. Well-established regulatory frameworks and dedicated funding for research contribute to high adoption rates of advanced neurostimulation solutions, particularly in high-income segments of the region.

In Europe, the Middle East, and Africa, there is a blend of mature markets and emerging economies that presents both opportunities and challenges. In Europe, rigorous clinical guidelines and a strong emphasis on safety drive innovation and quality, encouraging the development of devices that meet high standards. In contrast, parts of the Middle East and Africa are witnessing gradual market penetration, with a strong drive towards building sustainable healthcare ecosystems. Here, strategic investments in infrastructure and capacity-building are key to realizing market potential.

The Asia-Pacific region demonstrates vast potential, bolstered by rapid urbanization and increased healthcare investments. A combination of government initiatives, rising health awareness, and economic growth is catalyzing the demand for advanced neurostimulation devices in this region. The heterogeneity of healthcare systems in Asia-Pacific, ranging from highly developed urban centers to rural areas in transition, creates ample opportunities for diversified product strategies and targeted market interventions. Together, these regional insights highlight the need for localized strategies that address specific regulatory, economic, and cultural nuances across global markets.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Major Industry Players Fueling Innovation and Market Expansion

A competitive analysis of the market reveals that several notable companies are at the forefront of innovation in the neurostimulation space. Industry leaders, including Abbott Laboratories, Axonics, Inc., and Bioness, Inc., are leveraging their deep expertise and significant R&D resources to capture emerging market opportunities. These companies have successfully combined state-of-the-art technology with robust clinical evidence to ensure their devices meet stringent regulatory and performance standards. Such commitment to innovation drives their competitive edge and helps maintain leading positions in the market.

Boston Scientific Corporation and Cefaly Technology are also significant contributors, offering a wide range of devices tailored to address various clinical applications. The competitive landscape is further enriched by niche players such as Curonix LLC., InCube Labs., and Integra LifeSciences Holdings Corporation, who are swiftly adapting to market demands with focused solutions that cater to specific segments of the neurostimulation domain.

Additionally, companies like LivaNova PLC, Medtronic PLC, and MicroTransponder, Inc. have carved out robust market positions through a combination of technological expertise and comprehensive service models. Emerging innovators including Motif Neurotech, Inc., Nevro Corporation, ReShape Lifesciences, Inc, Saluda Medical Pty Ltd., SceneRay Co., Ltd, and Soterix Medical, Inc. are known for their innovative designs and agile market strategies that address emerging clinical needs. These key players, through continuous technological improvements and strategic market positioning, set new benchmarks in device performance and overall patient care.

The report delves into recent significant developments in the Neurostimulation Device Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Axonics, Inc., Bioness, Inc., Boston Scientific Corporation, Cefaly Technology, Curonix LLC., InCube Labs., Integra LifeSciences Holdings Corporation, LivaNova PLC, Medtronic PLC, MicroTransponder, Inc., Motif Neurotech, Inc., Nevro Corporation, ReShape Lifesciences, Inc, Saluda Medical Pty Ltd., SceneRay Co., Ltd, and Soterix Medical, Inc.. Actionable Recommendations to Strengthen Market Position

Industry leaders must adopt a holistic and forward-thinking approach to harness the full potential of the neurostimulation device market. It is imperative to invest in continuous R&D aimed at identifying and addressing clinical gaps that persist in current therapeutic solutions. Embracing emerging technologies like artificial intelligence and real-time data analytics can lead to the development of adaptive device solutions, fostering better clinical outcomes and streamlined patient management.

Strategic collaborations are another key area of focus. Alliances with academic institutions, clinical research centers, and technology providers can accelerate the translation of innovations from bench to bedside. By integrating advanced materials and improvements in power source technologies, companies can enhance device reliability and patient safety, further solidifying their market presence.

Furthermore, diversifying market strategies to address both mature and emerging regions is essential. Tailored approaches that integrate local market insights with global trends will help companies navigate regulatory complexities and economic variability. Robust post-market surveillance and continuous improvement protocols should be instituted to gather valuable feedback that drives iterative enhancements in device design and functionality. These recommendations serve as a roadmap for industry leaders seeking sustainable growth and a competitive edge in this dynamic market.

Conclusion: Charting the Future of Neurostimulation Devices

The evolving neurostimulation device market stands at the confluence of technology, medicine, and innovation. A robust understanding of market dynamics, ranging from product type and material selection to sophisticated applications and targeted end-user settings, provides an in-depth view that is critical for decision-makers. The integration of advanced materials, coupled with evolving power source technologies and adaptable device designs, is setting new standards for patient care and clinical efficacy.

Moreover, transformative shifts in global market dynamics and regional nuances underscore the importance of flexibility and responsiveness in strategy development. Industry leaders are now challenged to marry technological advancements with a deep understanding of localized market needs, thereby ensuring that innovations are both globally competitive and locally relevant. With key players driving continuous device innovation and a clear focus on patient-centric outcomes, the future of neurostimulation devices appears promising and well-aligned with the imperatives of modern healthcare.

As the market continues to expand, it is essential for stakeholders to remain agile, invest in research-driven innovation, and foster strategic partnerships. These efforts will not only enhance the clinical efficacy of neurostimulation devices but also contribute significantly to improved patient outcomes, ensuring long-term market sustainability.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising adoption of neurostimulation devices in pain management and treatment of chronic conditions
      • 5.1.1.2. Advancements in neurostimulation technologies enabling enhanced patient outcomes
      • 5.1.1.3. Increasing prevalence of neurological disorders coupled with the growing geriatric population
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of neurostimulation devices and procedures hindering adoption in emerging economies
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising investments in research and development to expand the scope of neurostimulation devices
      • 5.1.3.2. Growing demand for minimally invasive neurostimulation therapies across diverse medical applications
    • 5.1.4. Challenges
      • 5.1.4.1. Regulatory hurdles and long approval timelines for neurostimulation devices slowing market expansion
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product Type: Sacral nerve stimulators for improved bladder and bowel control
    • 5.2.2. End User: Home healthcare enabling long-term management of neurological conditions
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Neurostimulation Device Market, by Product Type

  • 6.1. Introduction
  • 6.2. Cochlear Implants
  • 6.3. Deep Brain Stimulators (DBS)
  • 6.4. Sacral Nerve Stimulators (SNS)
  • 6.5. Spinal Cord Stimulators (SCS)
  • 6.6. Vagus Nerve Stimulators (VNS)

7. Neurostimulation Device Market, by Material Type

  • 7.1. Introduction
  • 7.2. Metallic Biomaterials
  • 7.3. Polymeric Biomaterials

8. Neurostimulation Device Market, by Power Source

  • 8.1. Introduction
  • 8.2. Non-Rechargeable Neurostimulators
  • 8.3. Rechargeable Neurostimulators

9. Neurostimulation Device Market, by Age Group

  • 9.1. Introduction
  • 9.2. Adult
  • 9.3. Geriatric
  • 9.4. Pediatric

10. Neurostimulation Device Market, by Application

  • 10.1. Introduction
  • 10.2. Gastrointestinal Disorders
  • 10.3. Hearing Loss
  • 10.4. Neurological Disorders
    • 10.4.1. Dystonia
    • 10.4.2. Epilepsy
    • 10.4.3. Essential Tremor
    • 10.4.4. Parkinson's Disease
  • 10.5. Pain Management
    • 10.5.1. Cancer Pain
    • 10.5.2. Chronic Pain
  • 10.6. Sleep Apnea
  • 10.7. Urinary & Fecal Incontinence
    • 10.7.1. Bowel Disorders
    • 10.7.2. Overactive Bladder

11. Neurostimulation Device Market, by End User

  • 11.1. Introduction
  • 11.2. Ambulatory Surgery Centers (ASCs)
  • 11.3. Home Healthcare
  • 11.4. Hospitals
  • 11.5. Specialty Clinics

12. Americas Neurostimulation Device Market

  • 12.1. Introduction
  • 12.2. Argentina
  • 12.3. Brazil
  • 12.4. Canada
  • 12.5. Mexico
  • 12.6. United States

13. Asia-Pacific Neurostimulation Device Market

  • 13.1. Introduction
  • 13.2. Australia
  • 13.3. China
  • 13.4. India
  • 13.5. Indonesia
  • 13.6. Japan
  • 13.7. Malaysia
  • 13.8. Philippines
  • 13.9. Singapore
  • 13.10. South Korea
  • 13.11. Taiwan
  • 13.12. Thailand
  • 13.13. Vietnam

14. Europe, Middle East & Africa Neurostimulation Device Market

  • 14.1. Introduction
  • 14.2. Denmark
  • 14.3. Egypt
  • 14.4. Finland
  • 14.5. France
  • 14.6. Germany
  • 14.7. Israel
  • 14.8. Italy
  • 14.9. Netherlands
  • 14.10. Nigeria
  • 14.11. Norway
  • 14.12. Poland
  • 14.13. Qatar
  • 14.14. Russia
  • 14.15. Saudi Arabia
  • 14.16. South Africa
  • 14.17. Spain
  • 14.18. Sweden
  • 14.19. Switzerland
  • 14.20. Turkey
  • 14.21. United Arab Emirates
  • 14.22. United Kingdom

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Scenario Analysis
    • 15.3.1. Nexalin's Gen-3 Halo headset trial explores therapeutic potential for veterans with brain injuries
    • 15.3.2. ShiraTronics reveals groundbreaking results of implantable neurostimulation system for chronic migraine relief at ASPN Conference
    • 15.3.3. FDA's approval of Medtronic's Percept RC neurostimulator revolutionizes personalized DBS therapy
  • 15.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Axonics, Inc.
  • 3. Bioness, Inc.
  • 4. Boston Scientific Corporation
  • 5. Cefaly Technology
  • 6. Curonix LLC.
  • 7. InCube Labs.
  • 8. Integra LifeSciences Holdings Corporation
  • 9. LivaNova PLC
  • 10. Medtronic PLC
  • 11. MicroTransponder, Inc.
  • 12. Motif Neurotech, Inc.
  • 13. Nevro Corporation
  • 14. ReShape Lifesciences, Inc
  • 15. Saluda Medical Pty Ltd.
  • 16. SceneRay Co., Ltd
  • 17. Soterix Medical, Inc.

LIST OF FIGURES

  • FIGURE 1. NEUROSTIMULATION DEVICE MARKET MULTI-CURRENCY
  • FIGURE 2. NEUROSTIMULATION DEVICE MARKET MULTI-LANGUAGE
  • FIGURE 3. NEUROSTIMULATION DEVICE MARKET RESEARCH PROCESS
  • FIGURE 4. NEUROSTIMULATION DEVICE MARKET SIZE, 2024 VS 2030
  • FIGURE 5. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 6. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
  • FIGURE 9. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2030 (%)
  • FIGURE 11. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2024 VS 2030 (%)
  • FIGURE 13. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2024 VS 2030 (%)
  • FIGURE 15. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 17. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 18. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
  • FIGURE 19. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 20. AMERICAS NEUROSTIMULATION DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 21. AMERICAS NEUROSTIMULATION DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 22. UNITED STATES NEUROSTIMULATION DEVICE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 23. UNITED STATES NEUROSTIMULATION DEVICE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 24. ASIA-PACIFIC NEUROSTIMULATION DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 25. ASIA-PACIFIC NEUROSTIMULATION DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 26. EUROPE, MIDDLE EAST & AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 27. EUROPE, MIDDLE EAST & AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 28. NEUROSTIMULATION DEVICE MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 29. NEUROSTIMULATION DEVICE MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. NEUROSTIMULATION DEVICE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. NEUROSTIMULATION DEVICE MARKET DYNAMICS
  • TABLE 7. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY COCHLEAR IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY DEEP BRAIN STIMULATORS (DBS), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY SACRAL NERVE STIMULATORS (SNS), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY SPINAL CORD STIMULATORS (SCS), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY VAGUS NERVE STIMULATORS (VNS), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY METALLIC BIOMATERIALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY POLYMERIC BIOMATERIALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY NON-RECHARGEABLE NEUROSTIMULATORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY RECHARGEABLE NEUROSTIMULATORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY ADULT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY HEARING LOSS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY DYSTONIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY EPILEPSY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY ESSENTIAL TREMOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY PARKINSON'S DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY CANCER PAIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY CHRONIC PAIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY SLEEP APNEA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY BOWEL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY OVERACTIVE BLADDER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY AMBULATORY SURGERY CENTERS (ASCS), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 45. GLOBAL NEUROSTIMULATION DEVICE MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. AMERICAS NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. AMERICAS NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2030 (USD MILLION)
  • TABLE 49. AMERICAS NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 50. AMERICAS NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. AMERICAS NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 52. AMERICAS NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 53. AMERICAS NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2018-2030 (USD MILLION)
  • TABLE 54. AMERICAS NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 55. AMERICAS NEUROSTIMULATION DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 56. ARGENTINA NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. ARGENTINA NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. ARGENTINA NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2030 (USD MILLION)
  • TABLE 59. ARGENTINA NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 60. ARGENTINA NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. ARGENTINA NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 62. ARGENTINA NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 63. ARGENTINA NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2018-2030 (USD MILLION)
  • TABLE 64. ARGENTINA NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 65. BRAZIL NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. BRAZIL NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. BRAZIL NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2030 (USD MILLION)
  • TABLE 68. BRAZIL NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 69. BRAZIL NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. BRAZIL NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 71. BRAZIL NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 72. BRAZIL NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2018-2030 (USD MILLION)
  • TABLE 73. BRAZIL NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 74. CANADA NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. CANADA NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. CANADA NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2030 (USD MILLION)
  • TABLE 77. CANADA NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 78. CANADA NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. CANADA NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 80. CANADA NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 81. CANADA NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2018-2030 (USD MILLION)
  • TABLE 82. CANADA NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 83. MEXICO NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. MEXICO NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. MEXICO NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2030 (USD MILLION)
  • TABLE 86. MEXICO NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 87. MEXICO NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. MEXICO NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 89. MEXICO NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 90. MEXICO NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2018-2030 (USD MILLION)
  • TABLE 91. MEXICO NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 92. UNITED STATES NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. UNITED STATES NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. UNITED STATES NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2030 (USD MILLION)
  • TABLE 95. UNITED STATES NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED STATES NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED STATES NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED STATES NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED STATES NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED STATES NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED STATES NEUROSTIMULATION DEVICE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2030 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. ASIA-PACIFIC NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 108. ASIA-PACIFIC NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 109. ASIA-PACIFIC NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2018-2030 (USD MILLION)
  • TABLE 110. ASIA-PACIFIC NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 111. ASIA-PACIFIC NEUROSTIMULATION DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 112. AUSTRALIA NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. AUSTRALIA NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. AUSTRALIA NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2030 (USD MILLION)
  • TABLE 115. AUSTRALIA NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 116. AUSTRALIA NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. AUSTRALIA NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 118. AUSTRALIA NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 119. AUSTRALIA NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2018-2030 (USD MILLION)
  • TABLE 120. AUSTRALIA NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 121. CHINA NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. CHINA NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. CHINA NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2030 (USD MILLION)
  • TABLE 124. CHINA NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 125. CHINA NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. CHINA NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 127. CHINA NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 128. CHINA NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2018-2030 (USD MILLION)
  • TABLE 129. CHINA NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 130. INDIA NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. INDIA NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. INDIA NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2030 (USD MILLION)
  • TABLE 133. INDIA NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 134. INDIA NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. INDIA NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 136. INDIA NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 137. INDIA NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2018-2030 (USD MILLION)
  • TABLE 138. INDIA NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 139. INDONESIA NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. INDONESIA NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. INDONESIA NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2030 (USD MILLION)
  • TABLE 142. INDONESIA NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 143. INDONESIA NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. INDONESIA NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 145. INDONESIA NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 146. INDONESIA NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2018-2030 (USD MILLION)
  • TABLE 147. INDONESIA NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 148. JAPAN NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. JAPAN NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. JAPAN NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2030 (USD MILLION)
  • TABLE 151. JAPAN NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 152. JAPAN NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 153. JAPAN NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 154. JAPAN NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 155. JAPAN NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2018-2030 (USD MILLION)
  • TABLE 156. JAPAN NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 157. MALAYSIA NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. MALAYSIA NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. MALAYSIA NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2030 (USD MILLION)
  • TABLE 160. MALAYSIA NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 161. MALAYSIA NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 162. MALAYSIA NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 163. MALAYSIA NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 164. MALAYSIA NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2018-2030 (USD MILLION)
  • TABLE 165. MALAYSIA NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 166. PHILIPPINES NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. PHILIPPINES NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. PHILIPPINES NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2030 (USD MILLION)
  • TABLE 169. PHILIPPINES NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 170. PHILIPPINES NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 171. PHILIPPINES NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 172. PHILIPPINES NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 173. PHILIPPINES NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2018-2030 (USD MILLION)
  • TABLE 174. PHILIPPINES NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 175. SINGAPORE NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. SINGAPORE NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. SINGAPORE NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2030 (USD MILLION)
  • TABLE 178. SINGAPORE NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 179. SINGAPORE NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 180. SINGAPORE NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 181. SINGAPORE NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 182. SINGAPORE NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2018-2030 (USD MILLION)
  • TABLE 183. SINGAPORE NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 184. SOUTH KOREA NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. SOUTH KOREA NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. SOUTH KOREA NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2030 (USD MILLION)
  • TABLE 187. SOUTH KOREA NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 188. SOUTH KOREA NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 189. SOUTH KOREA NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 190. SOUTH KOREA NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 191. SOUTH KOREA NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2018-2030 (USD MILLION)
  • TABLE 192. SOUTH KOREA NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 193. TAIWAN NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 194. TAIWAN NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 195. TAIWAN NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2030 (USD MILLION)
  • TABLE 196. TAIWAN NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 197. TAIWAN NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 198. TAIWAN NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 199. TAIWAN NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 200. TAIWAN NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2018-2030 (USD MILLION)
  • TABLE 201. TAIWAN NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 202. THAILAND NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 203. THAILAND NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 204. THAILAND NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2030 (USD MILLION)
  • TABLE 205. THAILAND NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 206. THAILAND NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 207. THAILAND NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 208. THAILAND NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 209. THAILAND NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2018-2030 (USD MILLION)
  • TABLE 210. THAILAND NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 211. VIETNAM NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 212. VIETNAM NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 213. VIETNAM NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2030 (USD MILLION)
  • TABLE 214. VIETNAM NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 215. VIETNAM NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 216. VIETNAM NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 217. VIETNAM NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 218. VIETNAM NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2018-2030 (USD MILLION)
  • TABLE 219. VIETNAM NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 220. EUROPE, MIDDLE EAST & AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 221. EUROPE, MIDDLE EAST & AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 222. EUROPE, MIDDLE EAST & AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2030 (USD MILLION)
  • TABLE 223. EUROPE, MIDDLE EAST & AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 224. EUROPE, MIDDLE EAST & AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 225. EUROPE, MIDDLE EAST & AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 226. EUROPE, MIDDLE EAST & AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 227. EUROPE, MIDDLE EAST & AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2018-2030 (USD MILLION)
  • TABLE 228. EUROPE, MIDDLE EAST & AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 229. EUROPE, MIDDLE EAST & AFRICA NEUROSTIMULATION DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 230. DENMARK NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 231. DENMARK NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 232. DENMARK NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2030 (USD MILLION)
  • TABLE 233. DENMARK NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 234. DENMARK NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 235. DENMARK NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 236. DENMARK NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 237. DENMARK NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2018-2030 (USD MILLION)
  • TABLE 238. DENMARK NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 239. EGYPT NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 240. EGYPT NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 241. EGYPT NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2030 (USD MILLION)
  • TABLE 242. EGYPT NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 243. EGYPT NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 244. EGYPT NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 245. EGYPT NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 246. EGYPT NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2018-2030 (USD MILLION)
  • TABLE 247. EGYPT NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 248. FINLAND NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 249. FINLAND NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 250. FINLAND NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2030 (USD MILLION)
  • TABLE 251. FINLAND NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 252. FINLAND NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 253. FINLAND NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 254. FINLAND NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 255. FINLAND NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2018-2030 (USD MILLION)
  • TABLE 256. FINLAND NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 257. FRANCE NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 258. FRANCE NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 259. FRANCE NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2030 (USD MILLION)
  • TABLE 260. FRANCE NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 261. FRANCE NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 262. FRANCE NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 263. FRANCE NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 264. FRANCE NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2018-2030 (USD MILLION)
  • TABLE 265. FRANCE NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 266. GERMANY NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 267. GERMANY NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 268. GERMANY NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2030 (USD MILLION)
  • TABLE 269. GERMANY NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 270. GERMANY NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 271. GERMANY NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 272. GERMANY NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 273. GERMANY NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2018-2030 (USD MILLION)
  • TABLE 274. GERMANY NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 275. ISRAEL NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 276. ISRAEL NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 277. ISRAEL NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2030 (USD MILLION)
  • TABLE 278. ISRAEL NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 279. ISRAEL NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 280. ISRAEL NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 281. ISRAEL NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 282. ISRAEL NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2018-2030 (USD MILLION)
  • TABLE 283. ISRAEL NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 284. ITALY NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 285. ITALY NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 286. ITALY NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2030 (USD MILLION)
  • TABLE 287. ITALY NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 288. ITALY NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 289. ITALY NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 290. ITALY NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 291. ITALY NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2018-2030 (USD MILLION)
  • TABLE 292. ITALY NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 293. NETHERLANDS NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 294. NETHERLANDS NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 295. NETHERLANDS NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2030 (USD MILLION)
  • TABLE 296. NETHERLANDS NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 297. NETHERLANDS NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 298. NETHERLANDS NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 299. NETHERLANDS NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 300. NETHERLANDS NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2018-2030 (USD MILLION)
  • TABLE 301. NETHERLANDS NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 302. NIGERIA NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 303. NIGERIA NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 304. NIGERIA NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2030 (USD MILLION)
  • TABLE 305. NIGERIA NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 306. NIGERIA NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 307. NIGERIA NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 308. NIGERIA NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 309. NIGERIA NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2018-2030 (USD MILLION)
  • TABLE 310. NIGERIA NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 311. NORWAY NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 312. NORWAY NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 313. NORWAY NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2030 (USD MILLION)
  • TABLE 314. NORWAY NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 315. NORWAY NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 316. NORWAY NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 317. NORWAY NEUROSTIMULATION DEVICE MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 318. NORWAY NEUROSTIMULATION DEVICE MARKET SIZE, BY URINARY & FECAL INCONTINENCE, 2018-2030 (USD MILLION)
  • TABLE 319. NORWAY NEUROSTIMULATION DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 320. POLAND NEUROSTIMULATION DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 321. POLAND NEUROSTIMULATION DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 322. POLAND NEUROSTIMULATION DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2030 (USD MILLION)
  • TABLE 323. POLAND NEUROSTIMULATION DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 324. POLAND NEUROSTIMULATION DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 325. POLAND NEUROSTIMULATION DEVICE MARKET SIZE, BY NEUROLOGICAL DISORDER